Episode
The War No One Can Price | The Weekly Wrap – 3/22/2026
- Published
- Mar 22, 2026
- Duration seconds
- 4254
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/two-quants-and-a-financial-planner-6020642/episodes/the-war-no-one-can-price-the-weekly-wrap-3-22-2026/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/two-quants-and-a-financial-planner-6020642/the-war-no-one-can-price-the-weekly-wrap-3-22-2026.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
This week’s Excess Returns Weekly Wrap breaks down the biggest market drivers right now, including how markets price (or fail to price) war risk, why volatility signals are flashing unusual warnings, and what options market positioning is telling us about potential downside. Featuring Jared Dillian, Brent Kochuba and D.A. Wallach, the episode also explores how macro regime shifts are changing diversification, how the Fed is reacting to rising oil prices, and why biotech investing is essentially a portfolio of options. Topics Covered • Why markets struggle to price geopolitical risk and war probabilities • The concept of “willful ignorance” in market pricing of obvious risks • Implied vs realized volatility and what the VIX is signaling right now • Why volatility premium is near historic highs despite a relatively low VIX • How options flows and hedging activity influence stock market movements • The risk of a sudden volatility spike and what could trigger a VIX move to 40 • The Fed’s dilemma with rising oil prices and inflation vs demand destruction • Why oil shocks can be both inflationary and deflationary at the same time • The idea of “path of least embarrassment” in Fed policy decisions • Biotech investing explained as a “bag of options” with probabilistic outcomes • How drug development stages impact valuation and expected returns • Regime change in markets and why stock-bond correlations have flipped • The concept of non-stationary markets and constantly changing investing rules • Why most investors fail to adapt during regime shifts • The “Awesome Portfolio” and diversification across economic regimes • How options dealer positioning and gamma exposure can amplify market moves • Why OPEX (options expiration) can act as a turning point for markets • The shift fro…